This Is Qatar - Recent Advances in Primary Immunodysregulation Disorders (RAPID)

Recent Advances in Primary Immunodysregulation Disorders (RAPID)

An in-person conference on PIDs.

Muneeb M, May 02, 2024

Free

The in-person conference delves into the subject of primary/genetic immune dysregulation from a multidisciplinary standpoint, in collaboration with the MENAT-NIAID initiative. This event marks the debut of the primary Immune Dysregulation conference to be hosted by Sidra Medicine in the State of Qatar. The roster of invited speakers and the scientific committee includes esteemed global authorities in the field, notably featuring experts from the MENA region and the National Institutes of Allergy and Infectious Diseases (NIAID).

Physicians and scientists with an interest in this field are cordially invited to register. Registration is complimentary but space is limited, so we encourage you to register promptly to secure your spot. This conference is particularly tailored for basic/clinical researchers actively engaged in the field, as well as clinicians caring for patients with inborn errors of immunity (IEI), also known as primary immunodeficiencies (PID). Moreover, physicians from various specialties providing clinical care for these patients, including Gastroenterology, Hematology/Oncology, Pathology, Pulmonology, and Rheumatology, will find the event beneficial. The conference promises to deliver the latest updates for all those keen on staying informed about clinical and research advancements in the field.

Conference Objectives:

- Enhance early recognition and diagnosis of genetic Immune Dysregulation/Immune Deficiency disorders in the MENAT region.

- Demonstrate the role of a variety of clinical/pathology specialties and research in the diagnosis and management of Immune Dysregulation.

- Provide an overview of breakthroughs in cutting-edge and translational research in Immune Dysregulation.

- Highlight contributions from MENAT researchers to the investigation and management of Immune Dysregulation.

Target Audience:

- Clinicians and scientists involved in treating or studying patients with primary/genetic immune dysregulation disorders.

Date: 9-10 May 2024

Time: 8am - 6 pm

Venue: Sidra Auditorium

Note: Registration is free but required.

Sidra Medicine Auditorium, Doha Qatar